Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...
Daily Mail on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results